BACKGROUND: Individuals diagnosed with nonmelanoma skin cancer have a high risk of developing a second skin cancer diagnosis. We assessed whether a marker of immune function related to atopic allergy, IgE, was associated with diagnosis of subsequent squamous cell carcinoma (SCC) of the skin in patients with a previous skin cancer enrolled in a skin cancer prevention trial. METHODS: One hundred twelve individuals who developed an SCC (cases) were compared with 227 controls who did not develop SCC over the same followup period, matched on age, sex, and study center. Total, respiratory, and food-specific IgE were measured in the baseline or year one (prior to diagnosis) sera samples for each subject. RESULTS: IgE levels were higher in cases with SCC than controls (comparing the highest quartile with the lowest, OR(total IgE) = 1.44; 95% CI: 0.73-2.85; OR(respiratory IgE) = 2.43; 95% CI: 1.16-5.06; OR(food IgE) = 2.53; 95% CI: 1.19-5.35). The association between respiratory IgE and subsequent skin cancer was strongest among individuals with a tendency to sunburn (OR(respiratory IgE) = 3.82; 95% CI: 1.05-13.88) compared with those with a tendency to tan (OR(respiratory IgE) = 0.95; 95% CI: 0.20-4.76). Among 25 subjects with repeat IgE measurements taken over several years, IgE levels were remarkably stable (interclass coefficient = 0.90 for total IgE). CONCLUSION: These results indicate that allergy or allergy-associated IgE may be indicative of an immune phenotype that enhances risk of SCC, possibly via immune-associate inflammatory mediators. IMPACT: Our results indicate that controlling allergy and IgE levels may be a new avenue of skin cancer prevention in susceptible populations, and implicate immune mechanisms in skin carcinogenesis.
BACKGROUND: Individuals diagnosed with nonmelanoma skin cancer have a high risk of developing a second skin cancer diagnosis. We assessed whether a marker of immune function related to atopic allergy, IgE, was associated with diagnosis of subsequent squamous cell carcinoma (SCC) of the skin in patients with a previous skin cancer enrolled in a skin cancer prevention trial. METHODS: One hundred twelve individuals who developed an SCC (cases) were compared with 227 controls who did not develop SCC over the same followup period, matched on age, sex, and study center. Total, respiratory, and food-specific IgE were measured in the baseline or year one (prior to diagnosis) sera samples for each subject. RESULTS:IgE levels were higher in cases with SCC than controls (comparing the highest quartile with the lowest, OR(total IgE) = 1.44; 95% CI: 0.73-2.85; OR(respiratory IgE) = 2.43; 95% CI: 1.16-5.06; OR(food IgE) = 2.53; 95% CI: 1.19-5.35). The association between respiratory IgE and subsequent skin cancer was strongest among individuals with a tendency to sunburn (OR(respiratory IgE) = 3.82; 95% CI: 1.05-13.88) compared with those with a tendency to tan (OR(respiratory IgE) = 0.95; 95% CI: 0.20-4.76). Among 25 subjects with repeat IgE measurements taken over several years, IgE levels were remarkably stable (interclass coefficient = 0.90 for total IgE). CONCLUSION: These results indicate that allergy or allergy-associated IgE may be indicative of an immune phenotype that enhances risk of SCC, possibly via immune-associate inflammatory mediators. IMPACT: Our results indicate that controlling allergy and IgE levels may be a new avenue of skin cancer prevention in susceptible populations, and implicate immune mechanisms in skin carcinogenesis.
Authors: Alison Talbot-Smith; Lin Fritschi; Mark L Divitini; Dominic F J Mallon; Matthew W Knuiman Journal: Am J Epidemiol Date: 2003-04-01 Impact factor: 4.897
Authors: Robert P Dellavalle; Eric J Hester; Deborah L Stegner; Ann M Deas; Theresa R Pacheco; Stefan Mokrohisky; Joseph G Morelli; Lori A Crane Journal: Arch Dermatol Date: 2004-05
Authors: Michael E Ming; Ross Levy; Ole Hoffstad; Jennifer Filip; Bea B Abrams; Carlos Fernández; David J Margolis Journal: J Am Acad Dermatol Date: 2004-03 Impact factor: 11.527
Authors: Judy Cheng; M Scot Zens; Eric Duell; Ann E Perry; M Shane Chapman; Margaret R Karagas Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-02-10 Impact factor: 4.254
Authors: Cornelia Peterson; Rupin N Parikh; Meleha T Ahmad; Ashley A Campbell; Yassine Daoud; Nicholas Mahoney; Sepideh Siadati; Charles G Eberhart Journal: Int J Mol Sci Date: 2022-06-29 Impact factor: 6.208
Authors: Mi Zhou; Paige M Bracci; Lucie S McCoy; George Hsuang; Joseph L Wiemels; Terri Rice; Shichun Zheng; Karl T Kelsey; Margaret R Wrensch; John K Wiencke Journal: Int J Cancer Date: 2015-02-02 Impact factor: 7.316
Authors: Maria Argos; Lin Chen; Farzana Jasmine; Lin Tong; Brandon L Pierce; Shantanu Roy; Rachelle Paul-Brutus; Mary V Gamble; Kristin N Harper; Faruque Parvez; Mahfuzar Rahman; Muhammad Rakibuz-Zaman; Vesna Slavkovich; John A Baron; Joseph H Graziano; Muhammad G Kibriya; Habibul Ahsan Journal: Environ Health Perspect Date: 2014-10-17 Impact factor: 9.031
Authors: Bruno Gustavo Muzzi Carvalho Carneiro; Andy Petroianu; José Augusto Nogueira Machado; Paula Martins Ferreira Dos Anjos; Fabiana Rocha da Silva; Luiz Ronaldo Alberti; Vivian Resende; Sofia Candia Barrientos Journal: Sci Rep Date: 2021-09-13 Impact factor: 4.379